Galactose
| Galactose | |
|---|---|
|
|
| Identifiers | |
| CAS number | [] |
| PubChem | |
| MeSH | |
| Properties | |
| Molecular formula | C6H12O6 |
| Molar mass | 180.08 |
| Melting point |
167 degrees C |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
Galactose (Gal) (also called brain sugar[1]) is a type of sugar which is less sweet than glucose and not very water-soluble. It is considered a nutritive sweetener because it has food energy.
Galactan is a polymer of the sugar galactose. It is found in hemicellulose and can be converted to galactose by hydrolysis.
Sources
It is found in dairy products, in sugar beets and other gums and mucilages.
It is also synthesized by the body, where it forms part of glycolipids and glycoproteins in several tissues.
Relationship to lactose
Galactose is a monosaccharide constituent, together with glucose, of the disaccharide lactose. The hydrolysis of lactose to glucose and galactose is catalyzed by the enzyme lactase, a β-galactosidase. In the human body, glucose is changed into galactose in order to enable the mammary glands to secrete lactose.
Galactose and glucose are produced by hydrolysis of lactose by β-galactosidase. This enzyme is produced by the lac operon in Escherichia coli (E. coli).
Clinical significance
Two studies have suggested a possible link between galactose in milk and ovarian cancer.[2][3] Other studies show no correlation, even in the presence of defective galactose metabolism.[4][5] More recently, pooled analysis done by the Harvard School of Public Health showed no specific correlation between lactose containing foods and ovarian cancer, and showed statistically insignificant increases in risk for consumption of lactose at ≥30 g/d.[6] More research is necessary to ascertain possible risks.
There are some ongoing studies which suggest that galactose may have a role in treatment of focal segmental glomerulosclerosis (a kidney disease resulting in kidney failure and proteinuria).[citation needed] This effect is likely to be a result of binding of galactose to FSGS factor.[citation needed]
Structure and isomerism
The first and last -OH groups point the same way and the second and third -OH groups point the other way. D-Galactose has the same configuration at its penultimate carbon as D-glyceraldehyde. Galactose is a epimer of glucose.
Liver galactose metabolism
In the liver, galactose is converted to glucose 6-phosphate in the following reactions:
galacto- uridyl phosphogluco-
kinase transferase mutase
gal --------> gal 1 P ------------------> glc 1 P -----------> glc 6 P
^ \
/ v
UDP-glc UDP-gal
^ /
\___________/
epimerase
Metabolic disorders
There are 3 important disorders involving galactose:
| Name | Enzyme | Description |
| Galactosemia | Galactokinase | Causes cataracts and mental retardation. If a galactose-free diet starts sufficiently early, the cataracts will regress without complications however neurological damage is permanent. |
| UDPgalactose-4-epimerase deficiency | UDPgalactose-4-epimerase | Is extremely rare (only 2 reported cases). It causes nerve deafness. |
| Galactose-1-phosphate uridyl transferase deficiency | Galactose-1-phosphate uridyl transferase | Is the most problematic, as galactose-free diets do not have considerable long-term effects. |
ReferencesISBN links support NWE through referral fees
- ↑ Compact American Medical Dictionary. Houghton Mifflin Reference Books (1998). ISBN 0395884098
- ↑ Cramer D (1989). Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 130 (5): 904-10.
- ↑ Cramer D, Harlow B, Willett W, Welch W, Bell D, Scully R, Ng W, Knapp R (1989). Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 2 (8654): 66-71.
- ↑ Marc T. Goodman , Anna H. Wu , Ko-Hui Tung , Katharine McDuffie , Daniel W. Cramer , Lynne R. Wilkens , Keith Terada , Juergen K. V. Reichardt , and Won G. Ng (2002). Association of Galactose-1-Phosphate Uridyltransferase Activity and N314D Genotype with the Risk of Ovarian Cancer. Am. J. Epidemiol 156 (8): 693-701.
- ↑ Fung, W. L. Alan, Risch, Harvey, McLaughlin, John, Rosen, Barry, Cole, David, Vesprini, Danny, Narod, Steven A. (2003). The N314D Polymorphism of Galactose-1-Phosphate Uridyl Transferase Does Not Modify the Risk of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev 12 (7): 678-80.
- ↑ Genkinger, Jeanine M., Hunter, David J., Spiegelman, Donna, Anderson, Kristin E., Arslan, Alan, Beeson, W. Lawrence, Buring, Julie E., Fraser, Gary E., Freudenheim, Jo L., Goldbohm, R. Alexandra, Hankinson, Susan E., Jacobs, David R., Jr., Koushik, Anita, Lacey, James V., Jr., Larsson, Susanna C., Leitzmann, Michael, McCullough, Marji L., Miller, Anthony B., Rodriguez, Carmen, Rohan, Thomas E., Schouten, Leo J., Shore, Roy, Smit, Ellen, Wolk, Alicja, Zhang, Shumin M., Smith-Warner, Stephanie A. (2006). Dairy Products and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies. Cancer Epidemiol Biomarkers Prev 15: 364-372.
| |||||||||||||||||||||||||||||||||||||||||||||||
Credits
New World Encyclopedia writers and editors rewrote and completed the Wikipedia article in accordance with New World Encyclopedia standards. This article abides by terms of the Creative Commons CC-by-sa 3.0 License (CC-by-sa), which may be used and disseminated with proper attribution. Credit is due under the terms of this license that can reference both the New World Encyclopedia contributors and the selfless volunteer contributors of the Wikimedia Foundation. To cite this article click here for a list of acceptable citing formats.The history of earlier contributions by wikipedians is accessible to researchers here:
The history of this article since it was imported to New World Encyclopedia:
Note: Some restrictions may apply to use of individual images which are separately licensed.
